Product Information:

OPTRA Nebuliser Solution is a sterile, preservative-free liquid formulation intended for inhalation via nebulizer. While the exact active ingredient is not specified in the product name, based on common pharmaceutical naming conventions in Pakistan and regional markets, "OPTRA" most likely contains Levofloxacin or another antibiotic/bronchodilator.

However, levofloxacin nebulizer solutions are not standard or approved by major regulatory agencies (FDA, EMA). More plausibly, OPTRA Nebuliser Solution contains Formoterol Fumarate and/or Budesonide, commonly used in respiratory conditions.

⚠️ Critical Clarification:

Without explicit labeling of the active ingredient(s), the following description assumes OPTRA Nebuliser Solution contains a bronchodilator ± corticosteroid, as antibiotic nebulizers like levofloxacin are not standard care.

✅ Most Probable Composition (based on market trends in Pakistan):

1. Formoterol Fumarate 20 mcg/mL (long-acting beta-agonist)
2. Budesonide 500 mcg/mL or 1 mg/mL (inhaled corticosteroid)
3. (Often marketed as combination nebulizer solutions for COPD/asthma)

Assuming this profile, the description below applies:

Uses of (OPTRA NEBULISER SOL):

1. Chronic obstructive pulmonary disease (COPD) – maintenance treatment
2. Severe asthma – as add-on therapy when MDIs are insufficient
3. Bronchospasm prophylaxis in patients with reversible airway obstruction

Key Benefits of (OPTRA NEBULISER SOL):

1. Delivers medication directly to the lungs for rapid and targeted action
2. Suitable for patients unable to use metered-dose inhalers (e.g., elderly, children, acute distress)
3. Combination formulations reduce inflammation (steroid) and relax airway muscles (bronchodilator)
4. Nebulization allows controlled dosing in severe respiratory conditions

How To Use (OPTRA NEBULISER SOL):

1. Use only with a standard jet or ultrasonic nebulizer.
2. Pour the prescribed volume (e.g., 2–4 mL) into the nebulizer chamber.
3. Sit upright, place mouthpiece in mouth (or use mask), and breathe normally through the mouth until mist stops (~10–15 minutes).
4. Clean the nebulizer after each use as per manufacturer instructions.

Typical Dosage (Adults):

1. Formoterol/Budesonide combo: 2–4 mL twice daily
2. Always follow your doctor’s prescribed regimen.

📌 Do not inject or swallow—for inhalation use only.

When Not to Use (OPTRA NEBULISER SOL):

1. Hypersensitivity to formoterol, budesonide, or any excipients
2. Acute asthma attack or status asthmaticus (not for rescue)
3. Untreated pulmonary tuberculosis or fungal infections

Side Effects:

Common:

1. Throat irritation, cough, hoarseness
2. Headache, tremor (from formoterol)
3. Oral candidiasis (thrush)—rinse mouth after use

Serious (rare):

1. Paradoxical bronchospasm
2. Adrenal suppression (with long-term high-dose steroid use)
3. QT prolongation (formoterol in overdose)

Warnings & Precautions:

1. Not a rescue medication—use a short-acting beta-agonist (e.g., salbutamol) for acute attacks
2. Rinse mouth with water after each use to prevent thrush
3. Monitor growth in children on long-term inhaled steroids
4. Use caution in patients with cardiovascular disease, diabetes, or glaucoma

Additional Information:

1. Store below 30°C; protect from light
2. Discard unused portion after opening (single-dose vials)
3. Available by prescription in Pakistan